(Q50302445)
Statements
Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. (English)
1 reference
Christopher J McDougle
1 reference
David J Posey
1 reference
Ryan E Wiegand
1 reference
Jennifer Wilkerson
1 reference
Melissa Maynard
1 reference
Kimberly A Stigler
1 reference
1 October 2006
1 reference
16
1 reference
5
1 reference
599-610
1 reference